Related Experiment Videos

Gastric emptying in infants: response to metoclopramide depends on the underlying condition

P E Hyman1, C E Abrams, A Dubois

  • 1Department of Pediatrics, UCLA Harbor-UCLA Medical Center, Torrance 90502.

Insights

Metoclopramide significantly accelerated gastric emptying in infants with regurgitation or post-surgical gastroparesis. However, it did not improve gastric emptying in premature infants, with no observed side effects.

Area of Science:

  • Pediatric Gastroenterology
  • Pharmacology
  • Clinical Trials

Background:

  • Gastric emptying is crucial for infant nutrition and development.
  • Delayed gastric emptying (gastroparesis) can cause significant morbidity in infants.
  • Metoclopramide is a prokinetic agent with potential to improve gastric motility.

Purpose of the Study:

  • To evaluate the efficacy of metoclopramide in accelerating gastric emptying in infants.
  • To assess metoclopramide's effect on different causes of delayed gastric emptying in infants.

Main Methods:

  • A double-blind, placebo-controlled, randomized study design.
  • Utilized a phenol red dye dilution technique to measure gastric emptying.
  • Administered 1 mg/kg intravenous metoclopramide or placebo to infants with specific gastrointestinal conditions.

Main Results:

  • Metoclopramide doubled gastric emptying rates in infants with regurgitation (p<0.02).
  • Metoclopramide more than doubled gastric emptying in infants with post-surgical gastroparesis (p<0.05).
  • No significant effect on gastric emptying was observed in premature infants with gastroparesis.

Conclusions:

  • Metoclopramide is effective in accelerating gastric emptying for specific infant populations.
  • The prokinetic effect of metoclopramide varies depending on the underlying cause of gastroparesis.
  • Metoclopramide demonstrated a favorable safety profile in this infant cohort.

Related Concept Videos